Drug Discovery for Parkinson’s
Sometimes, personal experience can fuel accelerated research and promise advanced cures. Eight years ago at the age of 49, Jonathan Silverstein received a grim diagnosis: Parkinson’s...
The latest news and updates about NYSCF and our collaborators
Sometimes, personal experience can fuel accelerated research and promise advanced cures. Eight years ago at the age of 49, Jonathan Silverstein received a grim diagnosis: Parkinson’s...
NYSCF is proud to welcome our second Visiting Scholar: Dr. Vikram Khurana, a world-renowned research scientist and clinician. Dr. Khurana is Chief of the Movement Disorders...
Despite recent and encouraging advances in cancer research and clinical care, finding effective treatment for ovarian cancer patients remains a painstaking process of trial and error,...
This April, NYSCF convened biomedical leaders from across academia, industry, government and non-profits to discuss cutting-edge research at the 19th annual NYSCF Conference. This year’s conference,...
This Spring, NYSCF embarked on an exciting new chapter in our high school science education work by establishing a “sister-school” partnership with our West Side neighbor,...
We opened our 2025 annual meeting with a tribute to—and illuminating public conversation with—a legendary public health champion: physician and scientist Dr. Francis Collins, who for...
Uniting cutting-edge genomics, stem cell science, and AI-enabled data science to accelerate the discovery of life-changing therapies (Maine and New York — July 9, 2025) —...
Age-related macular degeneration (AMD) is a leading cause of vision loss in older adults, affecting almost 20 million Americans. Harnessing the transformative power of stem cells,...
Remembering NYSCF’s Friend, Mentor, and Board Member George Lazarus The New York Stem Cell Foundation deeply mourns the loss of Dr. George M. Lazarus, beloved friend,...
Largest collection of patient stem cell models of multiple sclerosis to date uncovers novel disease insights and opens the door for new treatments The Context: Multiple sclerosis...
Each year, NYSCF interns are exposed to innovative and cutting-edge science through our ten-week intensive curriculum and one-on-one mentorship program. These budding STEM leaders discover how...
Partnership combines advanced cellular tagging with ethnically diverse stem cell lines, addressing critical gaps in biomedical research Seattle, WA and New York, NY – September 4,...
Largest collection of patient stem cell models of multiple sclerosis to date uncovers novel disease insights and opens the door for new treatments NEW YORK, NY...
In her latest op-ed, NYSCF President and CEO Jennifer J. Raab underscores the urgent need for diversity in stem cell research to advance health equity. Discover...
NYSCF mourns the passing of our collaborator, supporter, and friend Jim Simons, who helped us launch many of our impactful programs. “All of us at NYSCF...
As a woman-founded and woman-led organization, advocacy for diversity, equity, inclusion, and belonging (DEIB) is in our DNA. Our founding CEO Susan Solomon always emphasized how...
The International Society for Stem Cell Research (ISSCR) recently announced its 2024 award recipients, with NYSCF – Robertson Stem Cell Investigator Jun Wu, PhD, of UT...
The Context: Brain organoids – 3D avatars of human brain tissue made from stem cells – are a revolutionary tool for studying disease. However, it has...
This week, NYSCF Board member, former interim CEO, and NYSCF – Robertson Stem Cell Investigator Alumnus Derrick Rossi, PhD, was elected to the National Academy of...
The New York Stem Cell Foundation is deeply saddened to learn about the passing of pioneering stem cell research advocate Brooke Ellison this week. Dr. Ellison...
Former Hunter College President Takes Helm of Globally Respected Institute Seeking Cures for Major Diseases Through Stem Cell Science
If you picture where brain disease research takes place, you might conjure an image of a laboratory full of white-coated scientists tinkering with microscopes and pipettes....
The Context: Cell therapies hold enormous promise for treating many of today’s most devastating diseases, but for them to be effective, we have to ensure that...
The Context: Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer deaths in the US, and is one of the most untreatable and lethal...
The Context: Scientists know that our risk for developing highly fatal blood cancers called ‘myeloid malignancies’ (such as acute myeloid leukemia) can be partially determined by...